Page 3 - Prnewswire Oncobeta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire oncobeta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Oncobeta Today - Breaking & Trending Today

Austrian skin cancer patients take part in EPIC-Skin clinical study

Austrian skin cancer patients take part in EPIC-Skin clinical study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , United Kingdom , Siroos Mirazei , Gerhard Dahlhoff , Shannond Brown , Oncobeta Gmb , Prnewswire Oncobeta , Therapeutic Nuclear Medicine , World Cancer Research Fund , Head Of The Nuclear Medicine Department , Skin Study , Personalised Irradiation , Nuclear Medicine , Ottakring Hospital , Patient Reported Outcome Measures , Clinical Study , Medical Director , Oncobeta Gmbh , Skin Cancer Therapy , Basal Cell Carcinomas , Squamous Cell Carcinomas , Disease Cancer Collaboration , Cancer Research , Skin Cancer , Radionuclide Therapy ,

Austrian skin cancer patients take part in EPIC-Skin clinical study

/PRNewswire/ OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised. ....

New York , United States , United Kingdom , Siroos Mirazei , Gerhard Dahlhoff , Shannond Brown , Oncobeta Gmb , Prnewswire Oncobeta , Therapeutic Nuclear Medicine , World Cancer Research Fund , Head Of The Nuclear Medicine Department , Skin Study , Personalised Irradiation , Nuclear Medicine , Ottakring Hospital , Patient Reported Outcome Measures , Clinical Study , Medical Director , Oncobeta Gmbh , Skin Cancer Therapy , Basal Cell Carcinomas , Squamous Cell Carcinomas , Disease Cancer Collaboration , Cancer Research , Skin Cancer , Radionuclide Therapy ,

New Non-Invasive Keloid Treatment using Rhenium-188 now available in South Africa

Share this article
Share this article
GARCHING, Germany and GAUTENG, South Africa, May 5, 2021 /PRNewswire/ OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies, announced today that the new Rhenium-188 treatment for keloids is now available in Gauteng, South Africa.
Even though keloids are common throughout the world, their epidemiology has not been adequately investigated. The development of Keloid scars is not only a cosmetic issue but also sometimes painful or limit mobility and may cause deterioration in the quality of life.The incidence of Keloids in South Africa is very high. According to research in Nigeria, Zambia & South Africa have shown incidence rates are as high as 16% (over 9 million). Some skin types are more prone to Keloids than others, but all can be affected. ....

South Africa , South Africans , Shannond Brown , Martin Magwaza , Oncobeta Gmb , Prnewswire Oncobeta , Nuclear Medicine , Device Company , Health Technology , Medical Device Company , Skin Cancer Therapy , Managing Director , Pain Management , Oncobeta Gmbh , அணு மருந்து , சாதனம் நிறுவனம் , ஆரோக்கியம் தொழில்நுட்பம் , மருத்துவ சாதனம் நிறுவனம் , தோல் புற்றுநோய் சிகிச்சை , நிர்வகித்தல் இயக்குனர் , வலி மேலாண்மை ,